Loading...
  • clinical
  • He led the initial clinical trials of the drug that resulted from the team's research, later known as rituximab, which demonstrated its safety and activity against CD20-positive B cells in patients with lymphoma. (wikipedia.org)
  • cells
  • The differences can cause donor cells to recognize recipient cells as foreign, and lead to an immune response against the recipient's tissues and organs. (cityofhope.org)
  • The graft contains donor T cells (T lymphocytes) that can be beneficial for the recipient by eliminating residual malignant cells. (wikipedia.org)
  • An immuno-competent graft is administered, with viable and functional immune cells. (wikipedia.org)
  • recipient
  • Its incidence and severity depends on several factors, such as prophylaxis method, donor/recipient matching, intensity of the condition- ing regimen and composition of the graft. (slideshare.net)
  • cancer
  • In recognition of his achievements, Dr. van den Brink has been awarded the Physician Scientist Award of the Howard Hughes Medical Institute, the Amy Strelzer Manasevit Scholar Award of the National Marrow Donor Program, and the Damon Runyon Scholar Award of the Cancer Research Fund, along with a scholarship from the V Foundation for Cancer Research. (wikipedia.org)